TickerFactsScreenerDevelopers

Oncotelic Therapeutics, Inc. (OTLC) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$24.73M2010: -$23.77M2011: -$9.65M2012: -$8.08M2013: -$8.28M2014: -$12.65M2015: -$13.65M2016: -$13.65M2017: -$13.81M2018: -$712.7K2019: -$6.64M2020: -$9.50M2021: -$9.39M2022: $5.09M2023: -$7.90M2024: -$4.52M2025: $249.28M$249.28M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$249.28M+5610.2%
2024-$4.52M+42.8%
2023-$7.90M-255.1%
2022$5.09M+154.3%
2021-$9.39M+1.2%
2020-$9.50M-43.2%
2019-$6.64M-831.3%
2018-$712.7K+94.8%
2017-$13.81M-1.2%
2016-$13.65M+0.0%
2015-$13.65M-8.0%
2014-$12.65M-52.8%
2013-$8.28M-2.5%
2012-$8.08M+16.3%
2011-$9.65M+59.4%
2010-$23.77M+3.9%
2009-$24.73M—